Skip to main content
Top
Published in: Endocrine 1/2014

01-09-2014 | Research Letter

Synergistic effect of androgen receptor (CAG repeat length) and endothelial nitric oxide synthase (Glu298Asp variant) gene polymorphisms on seminal parameters in men with idiopathic oligoasthenozoospermia

Authors: Nicola delli Muti, Giacomo Tirabassi, Eddi Buldreghini, Andrea Lenzi, Giancarlo Balercia

Published in: Endocrine | Issue 1/2014

Login to get access

Excerpt

Genetics play an important role in the multi-factorial aetiology of male infertility. In fact, some evidence suggests that both the androgen receptor (AR) gene and endothelial nitric oxide synthase (eNOS) gene are involved in this disease. Usually, the polymorphic length of AR CAG tract correlates inversely with receptor activity in various tissues [1]. However, the role of this polymorphism in male infertility is more complex, as amply proven by the inconsistent findings [24]. On the other hand, an association has been found between male infertility and the presence of the Glu298Asp single nucleotide polymorphism (SNP) of the eNOS gene [5]. The subsequent conformational change of eNOS protein structure and/or function with consequent nitric oxide (NO) hyperproduction could result in a negative influence on sperm function [5, 6] even if a recent study did not confirm this association [7]. …
Literature
1.
go back to reference G. Tirabassi, N. delli Muti, G. Corona, M. Maggi, G. Balercia, Androgen receptor gene CAG repeat polymorphism regulates the metabolic effects of testosterone replacement therapy in male postsurgical hypogonadotropic hypogonadism. Int. J. Endocrinol. 2013, 816740 (2013). doi:10.1155/2013/816740 PubMedCentralPubMed G. Tirabassi, N. delli Muti, G. Corona, M. Maggi, G. Balercia, Androgen receptor gene CAG repeat polymorphism regulates the metabolic effects of testosterone replacement therapy in male postsurgical hypogonadotropic hypogonadism. Int. J. Endocrinol. 2013, 816740 (2013). doi:10.​1155/​2013/​816740 PubMedCentralPubMed
2.
go back to reference Y.L. Giwercman, C. Xu, S. Arver, A. Pousette, R. Reneland, No association between the androgen receptor gene CAG repeat and impaired sperm production in Swedish men. Clin. Genet. 54, 435–436 (1998)PubMed Y.L. Giwercman, C. Xu, S. Arver, A. Pousette, R. Reneland, No association between the androgen receptor gene CAG repeat and impaired sperm production in Swedish men. Clin. Genet. 54, 435–436 (1998)PubMed
3.
go back to reference N. delli Muti, A. Agarwal, E. Buldreghini, A. Gioia, A. Lenzi, M. Boscaro, G. Balercia, Have androgen receptor gene CAG and GGC repeat polymorphisms an effect on sperm motility in infertile men? Andrologia (2013). doi:10.1111/and.12119 PubMed N. delli Muti, A. Agarwal, E. Buldreghini, A. Gioia, A. Lenzi, M. Boscaro, G. Balercia, Have androgen receptor gene CAG and GGC repeat polymorphisms an effect on sperm motility in infertile men? Andrologia (2013). doi:10.​1111/​and.​12119 PubMed
4.
go back to reference A. Ferlin, L. Bartoloni, G. Rizzo, A. Roverato, A. Garolla, C. Foresta, Androgen receptor gene CAG and GGC repeat lengths in idiopathic male infertility. Mol. Hum. Reprod. 10, 417–421 (2004)PubMedCrossRef A. Ferlin, L. Bartoloni, G. Rizzo, A. Roverato, A. Garolla, C. Foresta, Androgen receptor gene CAG and GGC repeat lengths in idiopathic male infertility. Mol. Hum. Reprod. 10, 417–421 (2004)PubMedCrossRef
5.
go back to reference E. Buldreghini, R.Z. Mahfouz, A. Vignini, L. Mazzanti, G. Ricciardo-Lamonica, A. Lenzi, A. Agarwal, G. Balercia, Single nucleotide polymorphism (SNP) of the endothelial nitric oxide synthase (eNOS) gene (Glu298Asp variant) in infertile men with asthenozoospermia. J. Androl. 31, 482–488 (2010)PubMedCrossRef E. Buldreghini, R.Z. Mahfouz, A. Vignini, L. Mazzanti, G. Ricciardo-Lamonica, A. Lenzi, A. Agarwal, G. Balercia, Single nucleotide polymorphism (SNP) of the endothelial nitric oxide synthase (eNOS) gene (Glu298Asp variant) in infertile men with asthenozoospermia. J. Androl. 31, 482–488 (2010)PubMedCrossRef
6.
go back to reference G. Balercia, S. Moretti, A. Vignini, M. Magagnini, F. Mantero, M. Boscaro, G. Ricciardo-Lamonica, L. Mazzanti, Role of nitric oxide concentrations on human sperm motility. J. Androl. 25, 245–249 (2004)PubMed G. Balercia, S. Moretti, A. Vignini, M. Magagnini, F. Mantero, M. Boscaro, G. Ricciardo-Lamonica, L. Mazzanti, Role of nitric oxide concentrations on human sperm motility. J. Androl. 25, 245–249 (2004)PubMed
7.
go back to reference Q. Yu, Y. Zhang, X. Yang, X. Yang, N. Li, L. Ye, X. Mao, Analysis of endothelial nitric oxide synthase (eNOS) G894T polymorphism and semen parameters in a Chinese Han population. Andrologia (2013). doi:10.1111/and.12113 Q. Yu, Y. Zhang, X. Yang, X. Yang, N. Li, L. Ye, X. Mao, Analysis of endothelial nitric oxide synthase (eNOS) G894T polymorphism and semen parameters in a Chinese Han population. Andrologia (2013). doi:10.​1111/​and.​12113
8.
go back to reference World Health Organization, WHO laboratory manual for the examination and processing of human semen, vol. 5 (World Health Organization, Geneva, 2010) World Health Organization, WHO laboratory manual for the examination and processing of human semen, vol. 5 (World Health Organization, Geneva, 2010)
9.
go back to reference A. Granata, G. Tirabassi, V. Pugni, G. Arnaldi, M. Boscaro, C. Carani, G. Balercia, Sexual dysfunctions in men affected by autoimmune Addison’s disease before and after short-term gluco- and mineralocorticoid replacement therapy. J. Sex Med. 10, 2036–2043 (2013)PubMedCrossRef A. Granata, G. Tirabassi, V. Pugni, G. Arnaldi, M. Boscaro, C. Carani, G. Balercia, Sexual dysfunctions in men affected by autoimmune Addison’s disease before and after short-term gluco- and mineralocorticoid replacement therapy. J. Sex Med. 10, 2036–2043 (2013)PubMedCrossRef
10.
go back to reference S. Holm, A simple sequentially rejective multiple test procedure. Scand. J. Stat. 6, 65–70 (1979) S. Holm, A simple sequentially rejective multiple test procedure. Scand. J. Stat. 6, 65–70 (1979)
11.
go back to reference L. Lazaros, N. Xita, A. Takenaka, N. Sofikitis, G. Makrydimas, T. Stefos, I. Kosmas, K. Zikopoulos, E. Hatzi, I. Georgiou, Semen quality is influenced by androgen receptor and aromatase gene synergism. Hum. Reprod. 27, 3385–3392 (2012)PubMedCrossRef L. Lazaros, N. Xita, A. Takenaka, N. Sofikitis, G. Makrydimas, T. Stefos, I. Kosmas, K. Zikopoulos, E. Hatzi, I. Georgiou, Semen quality is influenced by androgen receptor and aromatase gene synergism. Hum. Reprod. 27, 3385–3392 (2012)PubMedCrossRef
12.
go back to reference L. Lazaros, N. Xita, A. Takenaka, N. Sofikitis, G. Makrydimas, T. Stefos, I. Kosmas, K. Zikopoulos, E. Hatzi, I. Georgiou, Synergistic effect of follicle-stimulating hormone receptor and androgen receptor gene variants on semen quality. Andrologia 45, 339–344 (2013)PubMedCrossRef L. Lazaros, N. Xita, A. Takenaka, N. Sofikitis, G. Makrydimas, T. Stefos, I. Kosmas, K. Zikopoulos, E. Hatzi, I. Georgiou, Synergistic effect of follicle-stimulating hormone receptor and androgen receptor gene variants on semen quality. Andrologia 45, 339–344 (2013)PubMedCrossRef
Metadata
Title
Synergistic effect of androgen receptor (CAG repeat length) and endothelial nitric oxide synthase (Glu298Asp variant) gene polymorphisms on seminal parameters in men with idiopathic oligoasthenozoospermia
Authors
Nicola delli Muti
Giacomo Tirabassi
Eddi Buldreghini
Andrea Lenzi
Giancarlo Balercia
Publication date
01-09-2014
Publisher
Springer US
Published in
Endocrine / Issue 1/2014
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-014-0193-2

Other articles of this Issue 1/2014

Endocrine 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine